La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Evaxion Biotech Gestione
Gestione criteri di controllo 3/4
Evaxion Biotech's CEO is Christian Kanstrup, appointed in Sep 2023, has a tenure of less than a year. total yearly compensation is $373.00K, comprised of 31.1% salary and 68.9% bonuses, including company stock and options. directly owns 1.19% of the company’s shares, worth $206.78K. The average tenure of the management team and the board of directors is 2.9 years and 3.5 years respectively.
Informazioni chiave
Christian Kanstrup
Amministratore delegato
US$373.0k
Compenso totale
Percentuale dello stipendio del CEO | 31.1% |
Mandato del CEO | less than a year |
Proprietà del CEO | 1.2% |
Durata media del management | 2.9yrs |
Durata media del Consiglio di amministrazione | 3.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Evaxion: An Intriguing AI Vaccine Company With Big Pharma Collaboration
Mar 31Evaxion Biotech names Per Norlén as CEO
Oct 05Evaxion stock rises 11% as enrollment begins in trial of immunotherapy EVX-01 for skin cancer
Sep 21Evaxion Biotech ADS GAAP EPS of -$0.20 beats by $0.10
Aug 10Evaxion Biotech announces new CEO as Lars Wegner resigns
Aug 02Is Evaxion Biotech (NASDAQ:EVAX) In A Good Position To Invest In Growth?
Oct 27We're Hopeful That Evaxion Biotech (NASDAQ:EVAX) Will Use Its Cash Wisely
Jun 29Evaxion Biotech posts preclinical proof of concept data for AI-powered vaccine platform
Jun 03Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$15m |
Mar 31 2024 | n/a | n/a | -US$15m |
Dec 31 2023 | US$373k | US$116k | -US$22m |
Compensazione vs Mercato: Christian's total compensation ($USD373.00K) is below average for companies of similar size in the US market ($USD680.04K).
Compensazione vs guadagni: Insufficient data to compare Christian's compensation with company performance.
AMMINISTRATORE DELEGATO
Christian Kanstrup (52 yo)
less than a year
Mandato
US$373,000
Compensazione
Mr. Christian Kanstrup, MSc, serves as Chief Executive Officer of Evaxion Biotech A/S since September 01, 2023. He joined Evaxion Biotech A/S on September 01, 2023. He previously served as Executive Vice P...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Chief Executive Officer | less than a year | US$373.00k | 1.19% $ 206.8k | |
Co-Founder and Chief AI & Culture Officer | 16.6yrs | US$246.00k | 7.76% $ 1.3m | |
Interim CFO & COO | 2.4yrs | US$296.00k | 0.068% $ 11.8k | |
Chief Scientific Officer | 2.9yrs | US$269.00k | 0.068% $ 11.8k | |
Head of Business Development & Member of Advisory Board | 4.8yrs | Nessun dato | Nessun dato |
2.9yrs
Durata media
50yo
Età media
Gestione esperta: EVAX's management team is considered experienced (2.9 years average tenure).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Head of Business Development & Member of Advisory Board | 2.4yrs | Nessun dato | Nessun dato | |
Member of Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Advisory Board | no data | Nessun dato | Nessun dato | |
Independent Director | 3.3yrs | US$64.00k | 0.14% $ 23.6k | |
Member of Advisory Board | no data | Nessun dato | Nessun dato | |
Member of Advisory Board | no data | Nessun dato | Nessun dato | |
Independent Chairwoman of the Board | 3.8yrs | US$193.00k | 0.59% $ 102.0k | |
Independent Director | 6.6yrs | US$68.00k | 0.74% $ 129.3k |
3.5yrs
Durata media
61yo
Età media
Consiglio di amministrazione esperto: EVAX's board of directors are considered experienced (3.5 years average tenure).